VU LSC-EMBL Partnership for Genome Editing Technologies
4.7 (154) · € 21.00 · En Stock
EMBL and VU LSC, recognising the scientific and technological potential of uniting their complementary strengths in the field of targeted genome modification, decided to intensify existing links and build further institutional synergies by creating the Partnership for Genome Editing Technologies.
New partnership in Lithuania
One More Leader of a New Group at EMBL Partnership Institute Has Started His Work
Job: Junior Scientist (Ph.D.) in Genome Editor Engineering, Biochemistry - CRISPR Medicine
EMBLetc. Winter 2020/21 by European Molecular Biology Laboratory (EMBL) - Issuu
Diverse virus-encoded CRISPR-Cas systems include streamlined genome editors - ScienceDirect
Archive
Genome Editing
VU LSC-EMBL PI Researcher P. Pausch Receives EMBO Installation Grant
PDF) Genetically encoded phosphatidylserine biosensor for in vitro, ex vivo and in vivo labelling
Genetically encoded phosphatidylserine biosensor for in vitro, ex vivo and in vivo labelling, Cellular & Molecular Biology Letters
